Prostaglandin Receptor

Prostaglandin Receptor

Prostaglandin receptor, a sub-family of cell surface seven-transmembrane receptors, are the G-protein-coupled receptors.Ten distinct prostaglandin receptors on different cell types are currently known. G-protein-coupled receptors are a subclass of cell surface seven-transmembrane receptors that prostaglandins bind to. The following are the names of these receptors: FP-FP, IP1-2-IP1, IP2 receptors, TP-TP receptor, EP1-4-EP1, EP2, EP3, and EP4 receptors. A class of lipid molecules known as prostaglandins, which are produced enzymatically from fatty acids and resemble hormones, play vital roles in the bodies of animals. Ten distinct prostaglandin receptors on different cell types are currently known.

Prostaglandin Receptor related products

Structure Cat No. Product Name CAS No. Product Description
V74465 PDC31 (THG113.31; ILGHXDYK) 634586-40-6 PDC31 (THG113.31; ILGHXDYK) is an allosteric and noncompetitive inhibitor of the FP Prostaglandin Receptor.
V74467 Pexopiprant 932708-14-0 Pexopiprant is an oral antagonist of prostaglandin D2 receptor 2 (DP2) with Ki < 100nM.
V1881 PF-04418948 1078166-57-0 PF-04418948 is a novel, potent and selective prostaglandin EP2 receptor antagonist.
V7294 PGD2-IN-1 885066-67-1 PGD2-IN-1 is a DP receptor blocker (antagonist), disclosed in patent WO 2006044732 A2, example compound 15 (d), with IC50 of 0.3 nM.
V27653 Pizuglanstat 1244967-98-3 Pizuglanstat is a novel and potent prostaglandin D synthase inhibitor with the potential forDuchenne muscular dystrophy (DMD).
V74484 Prostaglandin D3 (PGD3) 71902-47-1 Prostaglandin D3 (PGD3) is a prostaglandin compound that works as an inhibitor (blocker/antagonist) of platelet aggregation and a modulator of autonomic neurotransmission in humans.
V4216 Ramatroban 116649-85-5 Ramatroban is a novel, potent and selectiveantagonist of thromboxane A2(TxA2) with an IC50of 14 nM.
V3669 RO1138452 221529-58-4 RO1138452 is a novel, potent and selective antagonist of the IP (prostacyclin) receptor.
V74460 SC 51089 free base 146033-03-6 SC 51089 free base is a selective prostaglandin receptor EP1 antagonist (inhibitor) with Kis of 1.3, 11.2, 17.5 and 61.1 μM for EP1, TP, EP3 and FP receptors respectively.
V74470 Selexipag-d7 1265295-21-3 Selexipag-d7 is the deuterium labelled form of Selexipag.
V5219 Setipiprant (ACT-129968; KYTH-105) 866460-33-5 Setipiprant (ACT-129968 and KYTH-105) is a novel, potent, orally bioavailable and selective CRTH2 antagonist.
V74459 Sulprostone (Sulprostone; SHB 286; CP-34089; ZK-57671) 60325-46-4 Sulprostone (SHB 286) is a specific EP3 receptor agonist.
V4395 TAFLUPROST 209860-87-7 Tafluprost (formerly MK-2452; MK2452; AFP-168; Taflotan; Zioptan) is a prostaglandin (PG) analog used as ananti-glaucoma drug.
V3782 Taprenepag isopropyl 1005549-94-9 Taprenepag isopropyl (foremrly PF-04217329 or PF-4217329) is a prodrug of CP-544326 (Taprenepag) which is a potent and selective agonist of EP2 (prostaglandin EP receptor 2) with IC50 of 10nM and EC50 of 2.8nM.
V74471 Taprostene (CG-4203) 108945-35-3 Taprostene (CG-4203) is a synthetic, chemically stable analog of prostacyclin (PGI2).
V3336 Terutroban 165538-40-9 Terutroban (S18886; S-18886) is a selective TP (thromboxane-prostaglandin receptor) receptor antagonist with antiplatelet activity and the potential to be used for the secondary prevention of acute thrombotic complications.
V3370 TG4-155 1164462-05-8 TG4-155 is a novel, potent and brain penetrant EP2 antagonist (KB = 2.4 nM) that is over 1000-fold less effective at EP4 (KB = 11.4 µM) and a panel of other receptors and channels.
V28667 Timapiprant sodium (OC000459) 950688-14-9 Timapiprant sodium (OC000459 sodium) is a potent, selective, and orally bioavailable D prostanoid receptor 2 (DP2, formerly known as CRTH2) antagonist with IC50 of 13 nM.
V74487 TP-16 2332972-26-4 TP-16 is a new selective EP4 antagonist (inhibitor) with IC50 of 2.1nm.
V74481 trans-Isoferulic acid-d3 1028203-97-5 trans-Isoferulic acid-d3 is the deuterated form of trans-Isoferulic acid.
Contact Us Back to top